RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+11.17%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.93B
AUM Growth
+$3.93B
Cap. Flow
-$151M
Cap. Flow %
-3.83%
Top 10 Hldgs %
32.87%
Holding
120
New
16
Increased
40
Reduced
11
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BMEA icon
101
Biomea Fusion
BMEA
$116M
$2.71M 0.07% 181,147
NVAX icon
102
Novavax
NVAX
$1.21B
$2.57M 0.07% 537,625
LPTX icon
103
Leap Therapeutics
LPTX
$12M
$2.43M 0.06% 911,937 +79,000 +9% +$210K
SPRB
104
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$2.05M 0.05% 2,609,125
VIGL
105
DELISTED
Vigil Neuroscience
VIGL
$1.61M 0.04% 471,958
XLO icon
106
Xilio Therapeutics
XLO
$36.3M
$1.56M 0.04% 1,440,759
OKUR
107
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$1.25M 0.03% 751,730
TLPH icon
108
Talphera
TLPH
$11.1M
$326K 0.01% 316,460
NUVB.WS icon
109
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$40.5K ﹤0.01% 134,028
AMGN icon
110
Amgen
AMGN
$155B
-74,500 Closed -$21.5M
RLAY icon
111
Relay Therapeutics
RLAY
$619M
-673,966 Closed -$7.42M
KRTX
112
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-515,024 Closed -$163M
ICVX
113
DELISTED
Icosavax, Inc. Common Stock
ICVX
-868,409 Closed -$13.7M
MRTX
114
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-835,776 Closed -$49.1M
INBX
115
DELISTED
Inhibrx, Inc. Common Stock
INBX
0
IMGN
116
DELISTED
Immunogen Inc
IMGN
-759,365 Closed -$22.5M